News

Archivel

20/03/2017

Archivel supports the 2017 World TB Day event in Barcelona

Archivel Farma is supporting a year more the activities organized in Barcelona around the World…

Adela Farré

Archivel

22/12/2016

TGT Group extends its participation in the capital of Archivel Farma

TGT Group, a strategic partner of Archivel Farma since January 2012, has increased its participation…

Adela Farré

Research

30/09/2016

Dr. Pere-Joan Cardona writes on TB therapeutic vaccines in ‘Frontiers in Microbiology’

The peer-reviewed journal Frontiers in Microbiology has just published an article by Dr. Pere-Joan Cardona, scientific advisor of…

Adela Farré

Press release

28/03/2014

Archivel Farma looks for partners to start the last stage of development of RUTI^® vaccine

Archivel has carried out a restructuring of its equipment to facilitate the entry of new…

Archivel Farma

Research

28/02/2014

Results of RUTI^®‘s Phase II clinical trial, published in Plos One

The prestigious magazine Plos One has just published the article "Safety, Tolerability, and Immunogenicity of…

Adela Farré

Press release

15/01/2012

Archivel secures funding to bring the anti-tuberculosis therapeutic vaccine RUTI® to market

TGT, an industrial group from Barcelona, Spain, has facilitated the exit of the financial investor…

Archivel Farma

Archivel supports the 2017 World TB Day event in Barcelona

TGT Group extends its participation in the capital of Archivel Farma

Dr. Pere-Joan Cardona writes on TB therapeutic vaccines in ‘Frontiers in Microbiology’

Archivel Farma looks for partners to start the last stage of development of RUTI^® vaccine

Results of RUTI^®‘s Phase II clinical trial, published in Plos One

Archivel secures funding to bring the anti-tuberculosis therapeutic vaccine RUTI® to market

Archivel on the media

TV3, QuèQuiCom
2016

TV3, Trenta Minuts
2011

Let's move your program forward

Whether you're in early R&D or preparing for your first clinical lot, our team is ready to discuss your needs and find the right solution for your program.

News

Archivel supports the 2017 World TB Day event in Barcelona

TGT Group extends its participation in the capital of Archivel Farma

Dr. Pere-Joan Cardona writes on TB therapeutic vaccines in ‘Frontiers in Microbiology’

Archivel Farma looks for partners to start the last stage of development of RUTI® vaccine

Results of RUTI®‘s Phase II clinical trial, published in Plos One

Archivel secures funding to bring the anti-tuberculosis therapeutic vaccine RUTI® to market

Archivel on the media

TV3, QuèQuiCom 2016

TV3, Trenta Minuts 2011

Let's move your program forward

Whether you're in early R&D or preparing for your first clinical lot, our team is ready to discuss your needs and find the right solution for your program.

Archivel Farma looks for partners to start the last stage of development of RUTI^® vaccine

Results of RUTI^®‘s Phase II clinical trial, published in Plos One

TV3, QuèQuiCom
2016

TV3, Trenta Minuts
2011